Idecabtagene Vicleucel (Ide-Cel) Versus Standard Regimens (srs) in Triple-Class–Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): KarMMa-3 Sub-Analysis of Black Patients
Clinical Lymphoma Myeloma and Leukemia(2024)
Key words
MM,CAR T cell therapy,multiple myeloma,triple-class exposed,progression-free survival,safety,phase 3
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined